# Summary of U.S. Department of State, Foreign Operations, and Related Programs Appropriations Bill
This document is a comprehensive federal appropriations bill for the Department of State, foreign operations, and related programs for fiscal year 2026. It contains detailed provisions governing the allocation, use, and reporting requirements for foreign assistance funds.
## Key Provisions
1. **Funding Restrictions**:
- Prohibits funding for abortions as a method of family planning or involuntary sterilization
- Bans direct assistance to governments of Cuba, North Korea, or Iran
- Prohibits assistance to countries that have experienced a military coup d'état
- Restricts assistance to countries in default on U.S. loans
- Prohibits funding for countries supporting international terrorism
2. **Notification Requirements**:
- Mandates 15-day advance notification to Congress for program changes exceeding $1 million or 10%
- Requires prior consultation for major program changes or reprogramming
- Requires notification for assistance to specific countries including Afghanistan, Iran, Syria, and others
3. **Funding Allocation Rules**:
- Specifies minimum funding levels for various programs
- Limits deviations from designated amounts to 10% (up to 50% for national security emergencies)
- Requires detailed reports on fund allocation at program, project, and activity levels
4. **Prohibited Expenditures**:
- Bans first-class travel in contravention of federal regulations
- Prohibits use of funds for tobacco promotion
- Restricts use of funds for entertainment at recreational events
- Requires computer network filters to block sexually explicit websites
5. **Reporting and Transparency**:
- Requires posting of reports on public websites within 45 days
- Mandates detailed beneficiary feedback collection for assistance programs
- Requires impact evaluations of foreign assistance programs
- Requires coordination of foreign assistance with Department of State programs
6. **Transfer Authorities**:
- Allows limited transfers between appropriations accounts (up to 5%)
- Requires prior consultation for significant transfers
- Prohibits transfers to other departments without specific authorization
This bill represents a comprehensive framework for U.S. foreign assistance, emphasizing accountability, transparency, national security considerations, and restrictions on certain types of funding. It contains numerous specific prohibitions and requirements aimed at ensuring U.S. foreign aid serves American interests while adhering to specific policy constraints.
HR 3492, the Protect Children’s Innocence Act, makes it a federal crime to perform genital or bodily mutilation or chemical castration on minors under 18, except for specific medical reasons. The bill broadly defines prohibited procedures to include gender transition-related surgeries (like hysterectomies or mastectomies) and medical treatments such as puberty blockers or cross-sex hormones administered to minors. It criminalizes these acts when they occur across state lines, involve payments, or use interstate commerce, while explicitly banning religious tradition as a defense. Exceptions include medically necessary procedures for health emergencies, childbirth, or conditions certified by a physician.
Halt All Lethal Trafficking of Fentanyl Act or the HALT Fentanyl Act This act permanently places fentanyl-related substances as a class into schedule I of the Controlled Substances Act. A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act. Under the act, offenses involving fentanyl-related substances are triggered by the same quantity thresholds and subject to the same penalties as offenses involving fentanyl analogues (e.g., offenses involving 100 grams or more trigger a 10-year mandatory minimum prison term). Additionally, the act establishes a new, alternative registration process for certain schedule I research. The act also makes several other changes to registration requirements for conducting research with controlled substances, including permitting a single registration for related research sites in certain circumstances, waiving the requirement for a new inspection in certain situations, and allowing a registered researcher to perform certain manufacturing activities with small quantities of a substance without obtaining a manufacturing registration. Finally, the act expresses the sense that Congress agrees with the interpretation of the Controlled Substances Act in United States v. McCray , a 2018 case decided by the U.S. District Court for the Western District of New York. In that case, the court held that butyryl fentanyl, a controlled substance, can be considered an analogue of fentanyl even though, under the Controlled Substances Act, the term controlled substance analogue specifically excludes a controlled substance.
